J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 7,810.00
-160.00 (-2.01%)
At close: Jun 5, 2026
J2KBIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4,029 | 2,673 | -1,653 | 4,844 | 2,086 | 1,623 |
Depreciation & Amortization | 1,500 | 1,500 | 1,118 | 634.44 | 556.88 | 506.57 |
Loss (Gain) From Sale of Assets | - | - | 4.58 | - | 39.95 | - |
Asset Writedown & Restructuring Costs | 17.65 | 17.65 | - | 6.74 | - | 99.33 |
Loss (Gain) From Sale of Investments | -44.09 | -44.09 | -85.7 | -36.58 | 64.4 | - |
Provision & Write-off of Bad Debts | 60.3 | 60.3 | -63.27 | 98.9 | 93.33 | 107.18 |
Other Operating Activities | 12.08 | -170.98 | 4,896 | 711.6 | 13.8 | 327.93 |
Change in Accounts Receivable | -1,905 | -1,905 | 2,733 | -3,302 | -789.83 | 177.25 |
Change in Inventory | -573.29 | -573.29 | 224.86 | -690.72 | -1,037 | -344.33 |
Change in Accounts Payable | -46.81 | -46.81 | -53.35 | 907.14 | 81.61 | -189.81 |
Change in Unearned Revenue | 8.67 | 8.67 | - | - | - | 1.2 |
Change in Other Net Operating Assets | 62.1 | 558.18 | -193.43 | 111.9 | 338.59 | -307.1 |
Operating Cash Flow | 3,120 | 2,078 | 6,928 | 3,285 | 1,448 | 2,001 |
Operating Cash Flow Growth | -26.19% | -70.01% | 110.88% | 126.92% | -27.66% | 134.83% |
Capital Expenditures | -421.69 | -866.78 | -6,904 | -1,369 | -119.66 | -798.8 |
Sale of Property, Plant & Equipment | - | - | - | - | 31.82 | - |
Cash Acquisitions | - | - | 10,580 | - | - | - |
Divestitures | - | - | - | - | - | 55.31 |
Sale (Purchase) of Intangibles | -98.13 | -107 | -83.79 | -217.52 | -60.54 | -16.98 |
Sale (Purchase) of Real Estate | 90 | -110.15 | -36.17 | - | - | -35.71 |
Investment in Securities | 3,152 | 5,865 | -5,950 | 993.47 | -1,001 | - |
Other Investing Activities | -72.98 | -80.47 | -672.09 | -1.37 | -15.88 | -458.61 |
Investing Cash Flow | 2,649 | 4,701 | -3,067 | -594.58 | -1,165 | -1,255 |
Short-Term Debt Issued | - | - | - | 1,600 | - | - |
Long-Term Debt Issued | - | - | - | 700 | 200 | 500 |
Total Debt Issued | - | - | - | 2,300 | 200 | 500 |
Short-Term Debt Repaid | - | - | -100 | -1,500 | -15.6 | -201.65 |
Long-Term Debt Repaid | - | -270.53 | -704.38 | -3,075 | -1,158 | -1,206 |
Total Debt Repaid | -277.61 | -270.53 | -804.38 | -4,575 | -1,174 | -1,408 |
Net Debt Issued (Repaid) | -277.61 | -270.53 | -804.38 | -2,275 | -973.96 | -908.01 |
Repurchase of Common Stock | - | - | -23.77 | - | - | - |
Common Dividends Paid | -49.62 | -49.62 | - | - | - | - |
Dividends Paid | -1,196 | -1,196 | - | -240.22 | - | - |
Other Financing Activities | -0 | -0 | -3.8 | -0 | - | 0 |
Financing Cash Flow | -1,474 | -1,467 | -831.95 | -2,515 | -973.96 | 1,092 |
Foreign Exchange Rate Adjustments | 11.01 | -3.89 | 9.45 | -0.02 | - | -0.02 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | -0 | -0 |
Net Cash Flow | 4,307 | 5,308 | 3,038 | 175.69 | -691.59 | 1,839 |
Free Cash Flow | 2,699 | 1,211 | 23.37 | 1,916 | 1,328 | 1,203 |
Free Cash Flow Growth | - | 5079.88% | -98.78% | 44.27% | 10.43% | - |
Free Cash Flow Margin | 7.33% | 3.67% | 0.07% | 6.73% | 8.28% | 8.46% |
Free Cash Flow Per Share | 462.98 | 207.84 | 4.23 | 380.01 | 263.40 | 19442.01 |
Cash Interest Paid | - | -6.49 | 68.8 | 119.2 | 108.54 | 42.21 |
Cash Income Tax Paid | 363.93 | 382.59 | 928.79 | 138.34 | 85.19 | -73 |
Levered Free Cash Flow | 1,686 | 365.77 | -1,615 | -752.45 | 269.87 | 1,534 |
Unlevered Free Cash Flow | 1,713 | 394.92 | -1,555 | -642.15 | 431.3 | 1,660 |
Change in Working Capital | -2,454 | -1,958 | 2,711 | -2,974 | -1,407 | -662.79 |